A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer

• Main Authors: Xiang Xu (Author), Lipeng Zhang (Author), Yan Qian (Author), Qian Fang (Author), Yongbiao Xiao (Author), Guizeng Chen (Author), Guojing Cai (Author), Alimujiang Abula (Author), Zhao Wang (Author), Ertao Zhai (Author), Jianhui Chen (Author), Shirong Cai (Author), Hui Wu (Author)
• Format: Book
• Published: MDPI AG, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune checkpoint inhibitors (ICIs) therapy has been successfully utilized in the treatment of multiple tumors, but only a fraction of patients with gastric cancer (GC) could greatly benefit from it. A recent study has shown that the tumor microenvironment (TME) can greatly affect the effect of immu...